Cancer News and Research

Latest Cancer News and Research

Researchers use dynamic time-series data to help improve accuracy of genome mapping

If you already have the sequenced map of an organism's genome but want to look for structural oddities in a sample, you can check the genomic barcode -- a series of distances between known, targeted sites -- by cutting a DNA sequence at those sites and examining the distance between the cuts.

30 Dec 2015

New model provides images of single cell with micrometer resolution

Thermal properties of cells regulate their ability to store, transport or exchange heat with their environment. So gaining control of these properties is of great interest for optimizing cryopreservation -- the process of freezing and storing blood or tissues, which is also used when transporting organs for transplants.

30 Dec 2015

Researchers suggest microorganisms in the womb set stage for health problems later in life

Researchers review importance of microorganisms that exist in the gut, suggesting perturbation of the environment during pregnancy, delivery and early infancy could impact the developing baby's early microbiome and set the stage for health problems later in life. The term "microbiome" refers to the trillions of organisms we harbor, on our skin and within our respiratory and gastrointestinal tracts.

30 Dec 2015

New oral breast cancer drug has potential to combat other types of cancer

Palbociclib, a new oral drug whose efficacy in combating breast cancer has been demonstrated alone and in combination with endocrine therapy, also has potential to combat other types of cancer, according to a literature review and additional original research conducted by experts at the Abramson Cancer Center in the University of Pennsylvania published this month in JAMA Oncology.

30 Dec 2015

Study reveals effects of plain packaging on tobacco products among Australian Indigenous people

Following the introduction of plain packaging on tobacco products in 2012, Australian Aboriginal and Torres Strait Islander people were 12 per cent less likely to think certain tobacco brands were less harmful than others, a new study found.

30 Dec 2015

Opioid prescribing guideline has immediate, sustained impact on prescribing rates

Emergency medicine physicians at Temple University Hospital have found that an opioid prescribing guideline had an immediate and sustained impact on opioid prescribing rates for minor conditions and chronic noncancer pain in an acute care setting.

30 Dec 2015

St. Jude scientists develop interactive tool to advance understanding of mutations that fuel pediatric cancer

St. Jude Children's Research Hospital scientists have developed a web application and data set that gives researchers worldwide a powerful interactive tool to advance understanding of the mutations that lead to and fuel pediatric cancer. The freely available tool, called ProteinPaint, is described in today's issue of the scientific journal Nature Genetics.

30 Dec 2015

One orgasm a day may reduce risk for prostate cancer

According to a new study, one orgasm a day could reduce a man's risk for prostate cancer. Researchers claim that while an orgasm provides pleasure during sex, it may also reduce the risk for prostate cancer. It also provides a number of health benefits such as a boost in your immunity, better sleep, and can even protect against heart disease.

29 Dec 2015

Discovery Life's new unscripted docudrama series highlights lifesaving work by SOM and Shock Trauma caregivers

Discovery Life's new unscripted docudrama series Shock Trauma: Edge of Life follows a team of medical professionals at the world-renown R Adams Cowley Shock Trauma Center, University of Maryland ("Shock Trauma").

29 Dec 2015

New Josie Robertson Surgery Center provides optimal care for patients undergoing cancer surgery

A major transformation is beginning in cancer surgery that will enable patients to go home within a day of undergoing a significant operation. The new Josie Robertson Surgery Center, opened by Memorial Sloan Kettering, exemplifies that transformation: a patient-focused facility that leverages technology and highly trained clinical teams to provide optimal care.

29 Dec 2015

Body can control pathogen-induced inflammatory response, find Georgia State researchers

The body can control inflammatory response triggered by invasions of microbial pathogens, such as bacteria and viruses, a discovery that could lead to the development of new therapeutic agents for uncontrolled inflammation, according to researchers at Georgia State University.

29 Dec 2015

E-cigarettes damage cells in ways that could lead to cancer

Adding to growing evidence on the possible health risks of electronic cigarettes, a lab team at the Veterans Affairs San Diego Healthcare System tested two products and found they damaged cells in ways that could lead to cancer. The damage occurred even with nicotine-free versions of the products.

29 Dec 2015

CMU researchers develop new method to survey learning-related changes in synapse properties

Carnegie Mellon University researchers have developed a new approach to broadly survey learning-related changes in synapse properties. In a study published in the Journal of Neuroscience and featured on the journal's cover, the researchers used machine-learning algorithms to analyze thousands of images from the cerebral cortex. This allowed them to identify synapses from an entire cortical region, revealing unanticipated information about how synaptic properties change during development and learning.

29 Dec 2015

Novel 'hypnosedation' technique offers new option for patients undergoing awake surgery for gliomas

Could hypnosis help to reduce the psychological trauma associated with "awake craniotomy" for brain cancers? A new "hypnosedation" technique offers a new alternative for patients undergoing awake surgery for gliomas, suggests a study in the January issue of Neurosurgery, official journal of the Congress of Neurological Surgeons, published by Wolters Kluwer.

29 Dec 2015

Study: Economic burden of cancer survivors varies by age and cancer site

Survivors of cancer pay thousands of dollars in excess medical expenditures every year, with the excess financial burden varying by age and cancer site, according to a new American Cancer Society study. The study, appearing early online in the Journal of the National Cancer Institute, says targeted efforts will be important to reduce the economic burden of cancer.

29 Dec 2015

FDA approves non-alcoholic Docetaxel Injection

Teikoku Pharma USA, Inc. announced today that the U.S. Food and Drug Administration has approved Docetaxel Injection, Non-Alcohol Formula ("Docetaxel Injection") for the treatment of breast cancer, non-small cell lung cancer, prostate cancer, gastric adenocarcinoma, and head and neck cancer.

29 Dec 2015

Immune enters into exclusive license with Atlante Biotech for new format of bispecific antibodies

Immune Pharmaceuticals Inc. a clinical-stage company developing novel therapies for the treatment of immuno-inflammatory diseases and cancer, today announced it has entered into an exclusive license with Atlante Biotech SAS, to the patents and know-how for a new format of bispecific antibodies.

29 Dec 2015

Rich Pharmaceuticals obtains FDA approval to begin Phase 1/2 study in AML and MDS patients

Rich Pharmaceuticals, Inc. is pleased to announce that the Company has received approval from the U.S. Food and Drug Administration to commence its Phase 1/2 clinical for the treatment of Acute Myelocytic Leukemia (AML) and Myelodysplastic Syndrome (MDS) patients.

28 Dec 2015

Genetic modification in esophagus can lead to esophageal cancer

A genetic modification in the mucous membrane of the esophagus, the Barrett esophagus, can lead to esophageal cancer. If certain biomarkers are contained in these tissue alterations, so-called miDNA, these are extremely short DNA strands, it could be an indication that this preliminary stage of esophageal cancer indeed leads to cancer.

28 Dec 2015

Northwest Biotherapeutics closes registered direct placement of $12.6M

Northwest Biotherapeutics, a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today announced the closing of its previously-announced registered direct placement with healthcare focused institutional investors, for gross proceeds of $12.6 million on the terms previously announced.

26 Dec 2015

Cancer News and Research

Latest Cancer News and Research

Researchers use dynamic time-series data to help improve accuracy of genome mapping

New model provides images of single cell with micrometer resolution

Researchers suggest microorganisms in the womb set stage for health problems later in life

New oral breast cancer drug has potential to combat other types of cancer

Study reveals effects of plain packaging on tobacco products among Australian Indigenous people

Opioid prescribing guideline has immediate, sustained impact on prescribing rates

St. Jude scientists develop interactive tool to advance understanding of mutations that fuel pediatric cancer

One orgasm a day may reduce risk for prostate cancer

Discovery Life's new unscripted docudrama series highlights lifesaving work by SOM and Shock Trauma caregivers

New Josie Robertson Surgery Center provides optimal care for patients undergoing cancer surgery

Body can control pathogen-induced inflammatory response, find Georgia State researchers

E-cigarettes damage cells in ways that could lead to cancer

CMU researchers develop new method to survey learning-related changes in synapse properties

Novel 'hypnosedation' technique offers new option for patients undergoing awake surgery for gliomas

Study: Economic burden of cancer survivors varies by age and cancer site

FDA approves non-alcoholic Docetaxel Injection

Immune enters into exclusive license with Atlante Biotech for new format of bispecific antibodies

Rich Pharmaceuticals obtains FDA approval to begin Phase 1/2 study in AML and MDS patients

Genetic modification in esophagus can lead to esophageal cancer

Northwest Biotherapeutics closes registered direct placement of $12.6M

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in